NSI Retail Advisors, LLC
- SEC CIK
- 0001866574
- Latest filing
- Feb 14, 2025
The latest 13F from NSI Retail Advisors, LLC covers Q4 2024 (filed Feb 14, 2025): 19 long positions worth $629.0M. The top 10 holdings make up 82.7% of the portfolio, and the largest is Invesco QQQ Trust Series I at 13.7%. Livermore has 16 filings on Form 13F from this institution, going back to Q2 2021.
What changed in Q4 2024
Share counts compared with Q3 2024: how many positions were new, added to, reduced or sold out, and the biggest buys and sells. Dollar amounts are estimated at the quarter-end prices implied by the filing.
- New
- 0
- Added
- 3
- Est. +$21.3M
- Reduced
- 4
- Est. −$2.83M
- Sold out
- 3
- Est. −$65.6M
Top 5 holdings
Share of this quarter's portfolio value
- Invesco QQQ Trust Series I46090E10313.7%$86.2M
- Vanguard Morningstar Growth ETF92290873613.5%$84.9M
- SPYSPDR S&P 500 ETF Trust
- Vanguard Morningstar Value ETF9229087449.5%$60.0M
- iShares Russell 2000 ETF4642876557.9%$49.8M
Share of portfolio
Top 5 holdings and the other 14 positions, by share of portfolio value
- Invesco QQQ Trust Series I13.7%
- Vanguard Morningstar Growth ETF13.5%
- SPY12.1%
- Vanguard Morningstar Value ETF9.5%
- iShares Russell 2000 ETF7.9%
- Other 14 positions43.3%
Biggest buys
New and added positions, by estimated amount bought
- iShares Russell 2000 ETF464287655+$20.7MAdded
- North Square Investm66263L593+$280.5KAdded
- North SQ Invstmnts T66263L775+$235.3KAdded
Largest weight increases
New and added positions, by percentage points of the portfolio gained
- iShares Russell 2000 ETF464287655+3.59 pp4.3% → 7.9%
- North SQ Invstmnts T66263L775+0.27 pp3.0% → 3.3%
- North Square Investm66263L593+0.21 pp1.3% → 1.5%
Biggest sells
Reduced and sold-out positions, by estimated amount sold
- iShares Tr464287432−$27.7MSold out
- Vanguard Health Care ETF92204A504−$27.1MSold out
- VanEck ETF Trust92189F106−$10.8MSold out
- State Street SPDR Portfolio S&P 500 ETF78464A854−$1.17MReduced
- North SQ Invstmnts T66263L825−$1.06MReduced
Largest weight decreases
Reduced and sold-out positions, by percentage points of the portfolio lost
- iShares Tr464287432−4.12 pp4.1% → 0.0%
- Vanguard Health Care ETF92204A504−4.04 pp4.0% → 0.0%
- VanEck ETF Trust92189F106−1.61 pp1.6% → 0.0%
- North SQ Invstmnts T66263L825−0.15 pp7.6% → 7.4%
Metrics
13F metrics for Q4 2024, computed only from the numbers in the filings. Definitions below.
- Portfolio value
- $629.0M
- −$42.9M (−6.4%) vs. prior quarter
- Positions
- 19
- −3 vs. prior quarter
- Top 10 concentration
- 82.7%
- Top 10 as share of value
- Turnover
- 3.3%
- Q4 2024, one quarter
- Average holding period
- 10.6 quarters
- Weighted by value
How these are calculated
- Portfolio value: the market value of all long positions in the 13F, as reported at quarter end, excluding options.
- Top 10 concentration: the combined value of the 10 largest positions as a share of portfolio value.
- Turnover: the smaller of this quarter's estimated purchases and estimated sales, divided by the average of this and last quarter's portfolio value. Estimates multiply the change in shares by the quarter-end price implied by the filing (market value divided by shares); new positions use this quarter's value and sold-out positions last quarter's. Only positions reported in shares count, and it is not calculated when the previous quarter was not filed.
- Average holding period: how many consecutive quarters each current position has been held (including this one; a quarter without the position or without a filing starts the count over), weighted by this quarter's value. Counting starts with the first 13F in Livermore (Q2 2021), so positions held before then are understated.
13F filings by quarter
15 quarters, going back to Q2 2021. Bars show each quarter's 13F portfolio value; quarters without a filing are left blank.
Peak $684.0M (Q2 2021)
| Quarter | Filed | Positions | Value | Top 3 holdings | Changes | Filing |
|---|---|---|---|---|---|---|
| Q4 2024 | Feb 14, 2025 | 19 | $629.0M | Invesco QQQ Trust Series IVanguard Morningstar Growth ETFSPY | vs. Q3 2024 | SEC |
| Q3 2024 | Nov 14, 2024 | 22 | $671.9M | Invesco QQQ Trust Series IVanguard Morningstar Growth ETFSPY | vs. Q2 2024 | SEC |
| Q2 2024 | Aug 14, 2024 | 38 | $570.1M | Invesco QQQ Trust Series ISPYVanguard Morningstar Growth ETF | vs. Q1 2024 | SEC |
| Q1 2024 | May 15, 2024 | 42 | $666.2M | Invesco QQQ Trust Series ISPYVanguard Morningstar Growth ETF | vs. Q4 2023 | SEC |
| Q4 2023 | Feb 14, 2024 | 47 | $619.2M | Invesco QQQ Trust Series ISPYVanguard Morningstar Value ETF | vs. Q3 2023 | SEC |
| Q3 2023 | Nov 13, 2023 | 40 | $471.9M | Vanguard Morningstar Value ETFVanguard Morningstar Growth ETFSPY | vs. Q2 2023 | SEC |
| Q2 2023 | Aug 14, 2023 | 51 | $590.1M | Vanguard Morningstar Value ETFVanguard Morningstar Growth ETFInvesco QQQ Trust Series I | vs. Q1 2023 | SEC |
| Q1 2023 | May 15, 2023 | 46 | $466.0M | Vanguard Morningstar Value ETFVanguard Morningstar Growth ETFSPY | vs. Q4 2022 | SEC |
| Q4 2022 | Feb 14, 2023 | 42 | $423.5M | Vanguard Morningstar Value ETFVanguard Morningstar Growth ETFNorth SQ Invstmnts T | vs. Q3 2022 | SEC |
| Q3 2022 | Nov 14, 2022 | 37 | $325.0M | Vanguard Morningstar Value ETFVanguard Morningstar Growth ETFNorth SQ Invstmnts T | vs. Q2 2022 | SEC |
| Q2 2022 | Aug 11, 2022 | 41 | $432.1M | Vanguard Morningstar Value ETFSPYVanguard Morningstar Growth ETF | vs. Q1 2022 | SEC |
| Q1 2022 | May 16, 2022 | 48 | $655.4M | Invesco QQQ Trust Series IVanguard Morningstar Value ETFVanguard Morningstar Growth ETF | vs. Q4 2021 | SEC |
| Q4 2021 | Feb 9, 2022 | 48 | $602.6M | Invesco QQQ Trust Series IVanguard Morningstar Growth ETFVanguard Morningstar Value ETF | vs. Q3 2021 | SEC |
| Q3 2021 | Nov 15, 2021 | 48 | $564.9M | Invesco QQQ Trust Series IVanguard Morningstar Growth ETFiShares Tr | vs. Q2 2021 | SEC |
| Q2 2021 | Aug 16, 2021Amended | 52 | $684.0M | Invesco QQQ Trust Series IVanguard Morningstar Growth ETFiShares Tr | – | SEC |